Business Description
Femtobiomed Inc
ISIN : KR7327610002
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.87 | |||||
Equity-to-Asset | -2.69 | |||||
Debt-to-Equity | -0.03 | |||||
Debt-to-EBITDA | -0.19 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -14.85 | |||||
Beneish M-Score | 26.47 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 40.8 | |||||
3-Year EBITDA Growth Rate | -3.5 | |||||
3-Year EPS without NRI Growth Rate | -28.3 | |||||
3-Year FCF Growth Rate | -24 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.93 | |||||
9-Day RSI | 41.2 | |||||
14-Day RSI | 41.27 | |||||
3-1 Month Momentum % | -18.08 | |||||
6-1 Month Momentum % | -32.22 | |||||
12-1 Month Momentum % | -6.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.17 | |||||
Quick Ratio | 0.16 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 398.57 | |||||
Days Sales Outstanding | 22.6 | |||||
Days Payable | 13.82 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -0.04 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.44 | |||||
Operating Margin % | -1063 | |||||
Net Margin % | -673.3 | |||||
FCF Margin % | -731.11 | |||||
ROA % | -61.11 | |||||
ROIC % | -27.71 | |||||
3-Year ROIIC % | 0.2 | |||||
ROC (Joel Greenblatt) % | -204.71 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 92.63 | |||||
EV-to-EBIT | -18.78 | |||||
EV-to-EBITDA | -26.29 | |||||
EV-to-Revenue | 126.34 | |||||
EV-to-FCF | -17.9 | |||||
Price-to-GF-Value | 0.16 | |||||
Earnings Yield (Greenblatt) % | -5.32 | |||||
FCF Yield % | -5.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Femtobiomed Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 333.954 | ||
EPS (TTM) (â‚©) | -380 | ||
Beta | - | ||
3-Year Sharpe Ratio | -0.75 | ||
3-Year Sortino Ratio | -1.02 | ||
Volatility % | 52.46 | ||
14-Day RSI | 41.27 | ||
14-Day ATR (â‚©) | 524.607971 | ||
20-Day SMA (â‚©) | 5526 | ||
12-1 Month Momentum % | -6.36 | ||
52-Week Range (â‚©) | 4600 - 10870 | ||
Shares Outstanding (Mil) | 8.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Femtobiomed Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Femtobiomed Inc Stock Events
Event | Date | Price (â‚©) | ||
---|---|---|---|---|
No Event Data |
Femtobiomed Inc Frequently Asked Questions
What is Femtobiomed Inc(XKRX:327610)'s stock price today?
When is next earnings date of Femtobiomed Inc(XKRX:327610)?
Does Femtobiomed Inc(XKRX:327610) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |